| Aβ1–42 | T-tau | T-tau/Aβ1–42 | P-tau | NFL | AβX-42 | AβX-42/X-40 | APPα | APPβ |
---|
AD vs DLB | | + ++ | + ++ | + ++ | | | + | + | + |
AD vs bvFTD | + ++ | + ++ | +++ | + ++ | + | + ++ | + ++ | + ++ | + ++ |
AD vs PNFA | + | | + | | + ++ | | | | |
AD vs SD | + ++ | + ++ | + ++ | + ++ | + ++ | + ++ | + ++ | | |
DLB vs bvFTD | + ++ | | + | | | + | | | |
DLB vs PNFA | | + | | + | + | | | + | + |
DLB vs SD | + ++ | | + | | + | + | + | | |
bvFTD vs PNFA | | + ++ | + ++ | + | | | + | + ++ | + ++ |
bvFTD vs SD | | | | | | | | | |
PNFA vs SD | + | + | + ++ | + | | | + | | |
- Biomarkers with “+” distinguish between groups with p < 0.05 from the unadjusted analysis, and “++” distinguish between groups with Bonferroni corrected p < 0.003
- Aβ amyloid beta, AD Alzheimer’s disease, APP amyloid precursor protein, bvFTD behavioural variant frontotemporal dementia, DLB dementia with Lewy bodies, PNFA progressive non-fluent aphasia, SD Semantic dementia, NFL neurofilament light chain, P-tau phosphorylated tau, T-tau total tau